Procept Biorobotics Corp Stock Today
| PRCT Stock | USD 97.29 1.98 1.99% |
Performance6 of 100
| Odds Of DistressLess than 23
|
Procept Biorobotics is selling for under 97.29 as of the 28th of November 2024; that is 1.99% down since the beginning of the trading day. The stock's last reported lowest price was 96.7. Procept Biorobotics has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Procept Biorobotics Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. Procept Biorobotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 54.11 M outstanding shares of which 5.9 M shares are at this time shorted by private and institutional investors with about 5.4 trading days to cover. More on Procept Biorobotics Corp
Moving together with Procept Stock
Moving against Procept Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Procept Stock Highlights
| CEO President | Reza Zadno |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
Procept Biorobotics Corp (PRCT) is traded on NASDAQ Exchange in USA. It is located in 150 Baytech Drive, San Jose, CA, United States, 95134 and employs 626 people. Procept Biorobotics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.37 B. Procept Biorobotics Corp conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 54.11 M outstanding shares of which 5.9 M shares are at this time shorted by private and institutional investors with about 5.4 trading days to cover.
Procept Biorobotics Corp currently holds about 269.81 M in cash with (108 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.05.
Check Procept Biorobotics Probability Of Bankruptcy
Ownership AllocationProcept Biorobotics owns a total of 54.11 Million outstanding shares. The majority of Procept Biorobotics Corp outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Procept Biorobotics Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Procept Biorobotics. Please pay attention to any change in the institutional holdings of Procept Biorobotics Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Procept Ownership Details
Procept Biorobotics Corp Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Procept Biorobotics market risk premium is the additional return an investor will receive from holding Procept Biorobotics long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0757 | |||
| Jensen Alpha | 0.5156 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.1054 |
Procept Stock Against Markets
Procept Biorobotics Corporate Management
| Matthew CFA | Vice Relations | Profile | |
| Hisham Shiblaq | Executive Officer | Profile | |
| Stacey Porter | Chief Officer | Profile | |
| Minni Vittal | VP Officer | Profile | |
| Alaleh Nouri | Chief EVP | Profile |
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.